Trial Profile
Clinical Trials Insight: 700030936
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 28 Feb 2008
Price :
$35
*
At a glance
- Drugs Ramucirumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors ImClone Systems
- 28 Feb 2008 New trial record.